Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - rosuvastatin calcium -

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

astrazeneca limited - rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin - film coated tablet - 10 mg - active: rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin excipient: calcium phosphate crospovidone hypromellose as opadry pink iron oxide red as opadry pink lactose monohydrate as opadry pink   magnesium stearate microcrystalline cellulose titanium dioxide as opadry pink triacetin as opadry pink - visacor is indicated to: - reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). - treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. ldl apheresis) or alone if such treatments are unavailable.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

astrazeneca limited - rosuvastatin calcium 20.8mg equivalent to 20 mg rosuvastatin;   - film coated tablet - 20 mg - active: rosuvastatin calcium 20.8mg equivalent to 20 mg rosuvastatin   excipient: calcium phosphate crospovidone hypromellose as opadry pink iron oxide red as opadry pink lactose monohydrate as opadry pink   magnesium stearate microcrystalline cellulose titanium dioxide as opadry pink triacetin as opadry pink - visacor is indicated to: - reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). - treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. ldl apheresis) or alone if such treatments are unavailable.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

astrazeneca limited - rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin;   - film coated tablet - 40 mg - active: rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin   excipient: calcium phosphate crospovidone hypromellose as opadry pink iron oxide red as opadry pink lactose monohydrate as opadry pink   magnesium stearate microcrystalline cellulose titanium dioxide as opadry pink triacetin as opadry pink - visacor is indicated to: - reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). - treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. ldl apheresis) or alone if such treatments are unavailable.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

astrazeneca limited - rosuvastatin calcium 5.2mg equivalent to 5 mg rosuvastatin;  ;  ;   - film coated tablet - 5 mg - active: rosuvastatin calcium 5.2mg equivalent to 5 mg rosuvastatin       excipient: calcium phosphate crospovidone hypromellose as opadry yellow iron oxide yellow as opadry yellow lactose monohydrate as opadry yellow   magnesium stearate microcrystalline cellulose titanium dioxide as opadry yellow triacetin as opadry yellow - visacor is indicated to: - reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). - treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. ldl apheresis) or alone if such treatments are unavailable.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - rosuvastatin calcium -

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - rosuvastatin calcium -